Use of a small-scale filler can result in increased filling efficiency.
Kashappa Goud Desai
Advertisement
Kashappa Goud Desai is scientific leader, Process Engineering and Analytics, Drug Product Development, GSK.
Articles by Kashappa Goud Desai
The authors summarize the current regulatory expectations regarding the number of PPQ batches required and provide potential approaches that can be used to determine and justify the number of PPQ batches.
This article provides an overview on important aspects related to bracketing strategies in Japan.
The objective of this study was to assess the impact of manufacturing-scale, freeze-thaw conditions on aggregation and subvisible particle formation of a monoclonal antibody solution (mAb-A; IgG1) using a small-scale model.
Advertisement
Latest Updated Articles
Impact of Manufacturing-Scale Freeze-Thaw Conditions on a mAb SolutionPublished: February 1st 2017 | Updated:
Japan Common Technical Document: Bracketing Strategies for the Manufacturing ProcessPublished: May 1st 2017 | Updated:
Stage 2 Process Validation: Regulatory Expectations and Approaches to Determine and Justify the Number of PPQ BatchesPublished: July 1st 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Strategies for Building Tech Talent in the Biopharma Industry (Part 4)
3
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
4
Why Product-Specific Strategies Matter in Advanced Therapy Manufacturing (Part 3)
5
